Chen Thomas C bought 2,732 shares of NEONC TECHNOLOGIES HOLDINGS, INC. at $3.66 for $10.0k on Nov 9, 2026

Buy
Form 4 code P. Open-market or private purchase of a non-derivative or derivative security.
CMO
CMO
Filed Nov 12, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
$9,999.12Shares × reported price
Shares traded
2,732Common Stock
Price per share
$3.66Reported price. Read footnotes for ranges.
% of reported position traded
11.15%This security and ownership context
Holdings after
27,235Indirect · By IRA
Trade date
Nov 9, 2026Buy
Filed
Nov 12, 2026, 6:15 AM ET3-day reporting delay
Accession
0001213900-26-118289Code P · Transaction 398177
How reported position traded is calculated

Shares purchased ÷ (holdings after − shares purchased). Estimated position before: 24,503 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Related trades are temporarily unavailable. Open the SEC filing for the complete report, or reload this page.

NTHI price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
NTHI · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Nov 19, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago −38%1w ago −33%1d ago −33%
Returns since7d30d90d180d1y

Footnotes in full

F1: Includes shares of common stock held by certain members of Reporting Person's immediate family of which Reporting Person disclaims beneficial ownership except to the extent of his pecuniary interest, if any, therein. F2: Such shares represent only Reporting Person's percentage interest in HCWG LLC. F3: Shares held by NeuCen Biomedical Co. Ltd., which is owned in part by Reporting Person's spouse. Reporting Person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest, if any, therein. F4: Shares held by T. R. Chen Third Family Limited Partnership, a NV limited partnership, of which Reporting Person and his spouse are the general partners with sole voting and dispositive power. Reporting Person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest, if any, therein. F5: Reporting Person disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest, if any, therein. F6: The aggregate number of shares (the "Shares") of common stock of Issuer purchased by the Reporting Person on the same date at different prices. F7: Represents the weighted average purchase price. The Shares were purchased at prices ranging from $4.31 to $4.38 per share, inclusive. Full information regarding the number of Shares sold at each price shall be provided to the Securities and Exchange Commission staff, Issuer or any security holder, upon request.